Mark Pruzanski
CIK 1559569 · President & CEO · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
82
Lifetime Open-Market Net
-$51.98M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EQ | Director | — | $2.81 | — | $0 | 9 | 2026-05-29 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 718,894 | $19.00 | $13.66M | -$51.98M | 72 | 2021-12-02 |
Recent Filings · Page 3 of 9
82 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-10-05 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −772 | -$32.5K | EDGAR |
| 2020-07-06 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −772 | -$35.9K | EDGAR |
| 2020-05-21 | EQ | Grant (A) | — | $0 | EDGAR |
| 2020-04-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −568 | -$33.2K | EDGAR |
| 2020-01-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +10,800 | $0 | EDGAR |
| 2020-01-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | −2,297 | -$295.0K | EDGAR |
| 2019-12-30 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | — | -$43.2K | EDGAR |
| 2019-11-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | — | -$4.37M | EDGAR |
| 2019-10-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −1,547 | -$101.9K | EDGAR |
| 2019-07-03 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −1,548 | -$122.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.